Adams Clinical

Adams Clinical is a specialized facility focusing on late-phase psychiatric and neurologic clinical trials. Operating under strict FDA regulations, the company conducts double-blind, randomized, placebo-controlled studies to test investigational drugs that have already undergone initial testing. The trials are overseen by nine full-time doctors who act as neutral third parties, ensuring unbiased results. Adams Clinical serves the pharmaceutical industry, which is mandated to use external testing facilities to minimize bias as per Chapter 21 of the Code of Federal Regulations, Part 54. The business model revolves around providing these essential testing services, with revenue generated from pharmaceutical companies seeking to validate their drug efficacy and safety. The company maintains high academic standards, with all raters holding doctorates in psychology or board certifications in psychiatry, and coordinators possessing degrees with plans for advanced medical education. Adams Clinical is committed to data integrity, achieved through careful participant selection, staff training, and the development of qualified raters. The company limits the number of trials open at any given time to maintain focus and quality in its depression research. Keywords: clinical trials, psychiatric, neurologic, FDA compliance, drug testing, pharmaceutical, depression research, data integrity, unbiased results, academic standards.